CG Oncology (CGON) Operating Leases (2023 - 2026)

CG Oncology (CGON) has 4 years of Operating Leases data on file, last reported at $3.5 million in Q1 2026.

• For the quarter ending Q1 2026, Operating Leases rose 349.3% year-over-year to $3.5 million; the trailing twelve-month figure through Mar 2026 stood at $3.5 million (up 349.3% YoY), and the FY2025 full-year result was $3.1 million, up 5873.08% from the prior year.
• Operating Leases for Q1 2026 stood at $3.5 million, up from $3.1 million in the prior quarter.
• Across five years, Operating Leases topped out at $3.5 million in Q1 2026 and bottomed at $52000.0 in Q4 2024.
• The 4-year median for Operating Leases is $475000.0 (2023), against an average of $1.2 million.
• The widest annual swing landed in 2024, when Operating Leases plunged 78.69%; it then soared 5873.08% in 2025.
• A 4-year view of Operating Leases shows it stood at $244000.0 in 2023, then slumped by 78.69% to $52000.0 in 2024, then jumped by 5873.08% to $3.1 million in 2025, then increased by 12.97% to $3.5 million in 2026.
• The last three Operating Leases figures came in at $3.5 million (Q1 2026), $3.1 million (Q4 2025), and $3.3 million (Q3 2025), per Business Quant data.

Peer Comparison